Skip to main content
OpenTrials
Completed

NCT Number: NCT03824613

Urinary miRNA in Endometrial Cancer Study

This study is a prospective feasibility study with the addition of a retrospective cohort study on the the expression of microRNA in urine in endometrial cancer patients.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of endometrial cancer
  • Age: 18 years or older

Exclusion criteria

  • Prior or coexisting other malignancies
  • Autoimmune disorders (other than diabetes mellitus)

Treatment and study plan

Urinary miRNA

Diagnostic Test

MiRNA detection in urine

Primary outcomes

  1. Accuracy of predictive value of miRNA test in detecting endometrial cancer

    Time frame: 6 months

    To determine if miRNA can distinguish endometrial cancer patients from healthy patients

Secondary outcomes

  1. Correlation to final histology

    Time frame: 6 months

    To determine how well miRNA correlates with final histology, i.e. can miRNA determine the subtype of endometrial cancer

Sponsors and collaborators

Lead sponsor

Royal Cornwall Hospitals Trust

Other

Registry information

Official study title

Urinary microRNA Expression in Endometrial Cancer Patients - a Feasibility Study

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jan 31, 2019
Registry last updated
Mar 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.